vimarsana.com
Home
Live Updates
Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript : vi
Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript : vi
Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript
GILD earnings call for the period ending March 31, 2024.
Related Keywords
Tennessee ,
United States ,
Japan ,
Maryland ,
Johanna Mercier ,
Salveen Richter Goldman Sachs ,
Merdad Parsey ,
Chris Schott Jpmorgan ,
Brian Abrahams ,
Carter Gould Barclays ,
Jacquie Ross ,
Cindy Perettie ,
Salveen Richter ,
Tyler Van Buren ,
Simon Baker Redburn Atlantic ,
Redburn Atlantic ,
Daina Graybosch Leerink ,
America Merrill Lynch ,
Terence Flynn Morgan Stanley ,
Randy Dickinson ,
Andrew Dickinson ,
Morgan Stanley ,
Michael Yee Jefferies ,
Chris Schott ,
James Shin Deutsche Bank Analyst ,
Goldman Sachs ,
Geoff Meacham Bank ,
Nvidia ,
Gilead Sciences ,
Department Of Corrections ,
Geoff Meacham At Bank ,
Company Analyst ,
James Shin At Deutsche Bank ,
Danielo Day ,
Motley Fool Stock Advisor ,
Stock Advisorservice ,
Stock Advisor ,
Chief Executive ,
Change Healthcare ,
Cell Therapy ,
Tennessee Oncology ,
Liver Disease ,
Daina Graybosch ,
Vice President ,
Umer Raffat ,
Geoff Meacham ,
Michael Yee ,
Maybei Ll ,
James Shin ,
Mohit Bansal ,
Fargo Securities ,
Trodelvy Phase ,
Simon Baker ,
Brian Skorney ,
Terence Flynn ,
Carter Gould ,
Leerink Partners ,
Executive Vice President ,
Deutsche Bank ,
Wells Fargo Securities ,
Chief Medical Officer ,
Chief Executive Officer ,
Hiv Prevention ,
Chief Commercial Officer ,